This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer's Top Takeaways: Novavax and Exxon Mobil

Cramer says the decline in Novavax stock has nothing to do with the company and its remarkable progress in developing needed vaccines.

Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud

Stocks get cheaper as they head lower and every day we're inching closer to a bottom, Cramer says.

'Mad Money' Lightning Round: Take PPG Over Sherwin-Williams

Cramer says to wait on Johnson Controls and avoid Jacobs Engineering.

Jim Cramer's Top Takeaways: Alcoa, GameStop, Teladoc

Cramer says Alcoa's coming split will bring out the value and he is playing GameStop.

Jim Cramer's 'Mad Money' Recap: 5 Groups You Once Loved but Now Hate

Cramer says these five groups must be approached with caution.

'Mad Money' Lightning Round: IBM Is Getting Attractive

Cramer says Radius Health is terrific but Blue Buffalo Pet Products is expensive compared to its growth rate.

Jim Cramer's Top Takeaways: Eli Lilly, Caterpillar, Opko Health

Eli Lilly is better than the market thinks, Cramer says. He's a believer in Opko Health but would avoid Caterpillar.

Jim Cramer's 'Mad Money' Recap: Don't Take It Personal but Your Stocks Are Going Down

It's not that you haven't picked great stocks, the market just stinks and is acting irrationally, Cramer confides.

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Up-and-coming private companies are 'disruptors' that can take on their publicly traded peers like an oncoming train, Cramer says.

'Mad Money' Lightning Round: Buy, Buy, Buy Terrific Dow Chemical

Cramer is in no hurry to buy Gilead Sciences right now and is no fan of Corning.

Page 2 of 401
Top Rated Stocks Top Rated Funds Top Rated ETFs